| Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine | New England Journal of Medicine | 2013 | 3.8K |
| Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group | Journal of Clinical Oncology | 2007 | 2.9K |
| BioGRID: a general repository for interaction datasets | Nucleic Acids Research | 2006 | 2.6K |
| Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study | Lancet Infectious Diseases, The | 2020 | 2.1K |
| The biochemistry of P-glycoprotein-mediated multidrug resistance | Annual Review of Biochemistry | 1989 | 1.9K |
| Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma | Annals of Neurology | 2007 | 1.7K |
| Drug resistance and the solid tumor microenvironment | Journal of the National Cancer Institute | 2007 | 1.5K |
| MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia | Nature Genetics | 2002 | 1.5K |
| A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer | New England Journal of Medicine | 2003 | 1.5K |
| Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection | Cell | 1993 | 1.5K |
| X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy | Nature Genetics | 2001 | 1.5K |
| European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013 | Blood | 2013 | 1.4K |
| The functions and regulation of the PTEN tumour suppressor | Nature Reviews Molecular Cell Biology | 2012 | 1.4K |
| Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points | Journal of Clinical Oncology | 1996 | 1.3K |
| Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil | Journal of Clinical Oncology | 2009 | 1.2K |
| Stereotactic body radiation therapy: the report of AAPM Task Group 101 | Medical Physics | 2010 | 1.2K |
| Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation | Clinical Infectious Diseases | 2004 | 1.2K |
| Initial genome sequencing and analysis of multiple myeloma | Nature | 2011 | 1.1K |
| Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial | Lancet, The | 2002 | 1.1K |
| Consistent Detection of 2019 Novel Coronavirus in Saliva | Clinical Infectious Diseases | 2020 | 1K |
| A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25 | Nature | 2008 | 1K |
| Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun | Nature | 1994 | 961 |
| Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial | Lancet, The | 2020 | 948 |
| a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer | Nature Medicine | 2000 | 928 |
| Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events | Circulation | 2002 | 907 |
